Account
Inquiry
Tirzepatide 15mg (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This pharmaceutical grade peptide is specifically designed for research applications in diabetes treatment studies.
The tirzepatide 15mg formulation demonstrates excellent stability when stored properly, making it ideal for laboratory research. Clinical studies have shown its potential in improving glycemic control through simultaneous activation of both GIP and GLP-1 receptors.
Our tirzepatide 15mg product is synthesized under strict quality control measures to ensure consistent purity and performance in research settings. The peptide is provided as a lyophilized powder for convenient reconstitution and use in various experimental protocols.
Important Note: This tirzepatide 15mg product is prepared by chemical synthesis and is intended for research use only. It is not for human consumption or clinical application. Researchers should handle all peptide materials with appropriate laboratory safety precautions.
